Holen Sie sich die Stockscreener-App
46.35
1.34%
-0.63
Handel nachbörslich:
46.05
-0.30
-0.65%
Schlusskurs vom Vortag:
$46.98
Offen:
$45.6
24-Stunden-Volumen:
509.68K
Relative Volume:
0.85
Marktkapitalisierung:
$1.40B
Einnahmen:
$1.37B
Nettoeinkommen (Verlust:
$54.85M
KGV:
26.14
EPS:
1.7729
Netto-Cashflow:
$123.71M
1W Leistung:
+8.60%
1M Leistung:
+41.61%
6M Leistung:
+20.73%
1J Leistung:
-9.38%
1-Tages-Spanne:
$45.24
$46.78
1-Wochen-Bereich:
$42.70
$49.00
52-Wochen-Spanne:
$31.44
$56.63
Conmed Corp Stock (CNMD) Company Profile
Firmenname
Conmed Corp
Sektor
Branche
Telefon
727-214-2974
Adresse
11311 CONCEPT BOULEVARD, LARGO, NY
Compare CNMD vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CNMD
Conmed Corp
|
46.35 | 1.31B | 1.37B | 54.85M | 123.71M | 1.7729 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Conmed Corp Stock (CNMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-17 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-06-12 | Herabstufung | Needham | Buy → Hold |
| 2025-04-28 | Herabstufung | Stifel | Buy → Hold |
| 2025-02-06 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-02-01 | Bestätigt | Needham | Buy |
| 2023-05-22 | Eingeleitet | CL King | Buy |
| 2023-03-27 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-03-21 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-03-02 | Fortgesetzt | BofA Securities | Neutral |
| 2021-10-06 | Hochstufung | Needham | Hold → Buy |
| 2021-07-15 | Eingeleitet | UBS | Buy |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2019-11-26 | Herabstufung | Needham | Buy → Hold |
| 2019-11-12 | Eingeleitet | JP Morgan | Overweight |
| 2019-10-31 | Bestätigt | Needham | Buy |
| 2019-10-04 | Bestätigt | Needham | Buy |
| 2019-08-22 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2019-04-18 | Eingeleitet | Stifel | Buy |
| 2019-04-16 | Bestätigt | Needham | Buy |
| 2019-01-23 | Bestätigt | Needham | Buy |
| 2018-10-16 | Eingeleitet | Barclays | Equal Weight |
| 2018-08-07 | Bestätigt | Needham | Buy |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-04-26 | Bestätigt | Needham | Buy |
| 2018-02-01 | Bestätigt | Needham | Buy |
| 2017-07-27 | Bestätigt | Needham | Buy |
| 2017-04-27 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2017-04-27 | Bestätigt | Needham | Buy |
| 2016-11-18 | Bestätigt | Needham | Buy |
| 2016-07-28 | Herabstufung | Leerink Partners | Outperform → Mkt Perform |
| 2016-04-28 | Bestätigt | Needham | Buy |
| 2015-10-22 | Bestätigt | Northland Capital | Market Perform |
Alle ansehen
Conmed Corp Aktie (CNMD) Neueste Nachrichten
Conmed Corp (CNMD) Cash Flow - TradingKey
Conmed Corp (CNMD) Institutional Confidence - TradingKey
Conmed Corp (CNMD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Principal Financial Group Inc. Has $7.45 Million Stock Position in CONMED Corporation $CNMD - MarketBeat
Conmed Corp (CNMD) Balance Sheet - TradingKey
Conmed Market Sentiment - Benzinga España
Conmed Corp (CNMD) Valuation: PE, PB & Fair Value Analysis - TradingKey
CONMED Corporation (CNMD) Stock Forecasts - Yahoo Finance
TradingKey - TradingKey
Conmed Corp (CNMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Conmed Corp (CNMD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CNMD|Conmed Corp|Price:43.500|Chg%:+0.820 - TradingKey
Conmed Corp (CNMD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Conmed Corp (CNMD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Electrosurgery Market Projected to Reach $11.59 Billion by 2031 as Demand for Minimally Invasive Procedures Rises - GlobeNewswire Inc.
Conmed Corp (CNMD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Conmed Corp (CNMD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
CONMED Expands AirSeal Robotic Solution for da Vinci 5 Hex Cannula - Zacks Investment Research
Conmed’s AirSeal Robotic Solution OK’ed for Intuitive da Vinci 5 Hex Cannula - Medical Product Outsourcing
CONMED expands AirSeal compatibility to da Vinci 5 platform - Investing.com
CONMED expands AirSeal compatibility to da Vinci 5 platform By Investing.com - Investing.com Canada
Intuitive’s 8mm hex cannula is now compatible with CONMED’s AirSeal - Stock Titan
CONMED (NYSE:CNMD) Faces A Crucial Robotics Test - Kalkine Media
Bessemer Group Inc. Purchases 36,940 Shares of CONMED Corporation $CNMD - MarketBeat
In 40 Robotic Prostatectomies, AirSeal Had Fewer Nociceptive Events per Hour - Stock Titan
CONMED (NYSE:CNMD) Stock Rating Upgraded by Wall Street Zen - MarketBeat
CNMD5600366 Bond Profile — Key Metrics - TradingView
Form 4 CONMED Corporation For: 17 July By Investing.com - Investing.com Nigeria
CONMED Corp (NYSE: CNMD) grants CFO stock options and RSUs - Stock Titan
CONMED (NYSE: CNMD) CFO John Gallagher reports zero common stock ownership - Stock Titan
ETFs Investing in CONMED Corporation Stocks - TradingView
Understanding Momentum Shifts in (CNMD) - Stock Traders Daily
CONMED (NYSE:CNMD) Faces A Tougher Market Test - Kalkine Media
CONMED Jumped 10%—Is This Takeover Rally Already Dangerous? - Smartkarma
Needham reiterates Hold on Conmed stock amid sale exploration - Investing.com
CONMED (CNMD) Stock Trades Up, Here Is Why - Yahoo! Finance Canada
CONMED (NYSE:CNMD) Sees Large Volume IncreaseWhat's Next? - MarketBeat
CNMD Jumps As Conmed Weighs Sale After PE Interest - StocksToTrade
Kimberly Lockwood Net Worth (2026) - GuruFocus
CNMD Jumps As Conmed Weighs Strategic Sale Options - timothysykes.com
CNMD Stock Surges As Much As 10% After-Hours On Reports Of Private Equity Takeover Interest - Yahoo Finance
Conmed shares jump on potential sale report By Investing.com - Investing.com Nigeria
A Look at Conmed Corp (CNMD) After 4.9% Gain -- GF Value $74.38 vs Price $38.48 - GuruFocus
CNMD Stock Pops As New CFO Arrives And Street Stays Cautious - timothysykes.com
Conmed shares jump on potential sale report - Investing.com
CONMED (NYSE:CNMD) Upgrade Puts Recovery In Focus - Kalkine Media
CONMED (NYSE:CNMD) Upgraded at BMO Capital Markets - MarketBeat
CONMED (NYSE:CNMD) Stock Price Up 11.6%Still a Buy? - MarketBeat
CNMD stock holds steady as focus shifts to the business - Ad-hoc-news.de
CONMED (CNMD) Stock Fair Value Moves Lower As Analysts Turn More Cautious - Yahoo Finance
CONMED stock centers on its medical device platform - ad-hoc-news.de
Finanzdaten der Conmed Corp-Aktie (CNMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
Conmed Corp-Aktie (CNMD) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Council LaVerne H | Director |
Jun 02 '26 |
Option Exercise |
0.00 |
668 |
0 |
4,716 |
| Farkas Charles | Director |
Jun 02 '26 |
Option Exercise |
0.00 |
668 |
0 |
15,527 |
| Kaye Mark | Director |
Jun 02 '26 |
Option Exercise |
0.00 |
668 |
0 |
820 |
| Schwarzentraub Barbara J | Director |
Jun 02 '26 |
Option Exercise |
0.00 |
668 |
0 |
5,012 |
| Lalomia Brent | Executive VP RA, QA |
Mar 06 '26 |
Option Exercise |
0.00 |
75 |
0 |
941 |
| Kaye Mark | Director |
Feb 24 '26 |
Option Exercise |
0.00 |
152 |
0 |
152 |
| Glaze Richard | Chief Information Officer |
Nov 21 '25 |
Sale |
41.21 |
257 |
10,591 |
0 |
| Glaze Richard | Chief Information Officer |
Nov 20 '25 |
Option Exercise |
0.00 |
375 |
0 |
375 |
1.04%
11.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):